Broadening the antibacterial spectrum of histidine kinase autophosphorylation inhibitors via the use of ε-poly-L-lysine capped mesoporous silica-based nanoparticles
(si apre in una nuova finestra)
Autori:
Nadya Velikova, Nuria Mas, Laura Miguel-Romero, Lorena Polo Aguado, Ellen Stolte, Edoardo Zaccaria, Rui Cao, Nico Taverne, José Ramón Murguía, Ramon Martinez-Manez, Alberto Marina, Jerry Wells
Pubblicato in:
Nanomedicine: Nanotechnology, Biology and Medicine, 2016, ISSN 1549-9634
Editore:
Elsevier BV
DOI:
10.1016/j.nano.2016.09.011
Evaluation of Galleria mellonella larvae for studying the virulence of Streptococcus suis
(si apre in una nuova finestra)
Autori:
Nadya Velikova, Kevin Kavanagh, Jerry M. Wells
Pubblicato in:
BMC Microbiology, Numero 16/1, 2016, ISSN 1471-2180
Editore:
BioMed Central
DOI:
10.1186/s12866-016-0905-2
Rationale and Prospects of Targeting Bacterial Two-component Systems for Antibacterial Treatment of Cystic Fibrosis Patients
(si apre in una nuova finestra)
Autori:
Nadya Velikova, Jerry Wellsa
Pubblicato in:
Current Drug Targets, Numero 17/999, 2016, Pagina/e 1-1, ISSN 1389-4501
Editore:
Bentham Science Publishers
DOI:
10.2174/1389450117666160208145934#sthash.jhGLdkL8.dpuf
Putative histidine kinase inhibitors with antibacterial effect against multi-drug resistant clinical isolates identified by in vitro and in silico screens
(si apre in una nuova finestra)
Autori:
Nadya Velikova, Simone Fulle, Ana Sousa Manso, Milena Mechkarska, Paul Finn, J. Michael Conlon, Marco Rinaldo Oggioni, Jerry M. Wells, Alberto Marina
Pubblicato in:
Scientific Reports, Numero 6, 2016, Pagina/e 26085, ISSN 2045-2322
Editore:
Nature Publishing Group
DOI:
10.1038/srep26085
